Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 90/100

Amgen Inc at Cowen Health Care Conference Transcript

Mar 12, 2019 / 01:20PM GMT
Release Date Price: $184.35 (+0.17%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. Well, good morning, everybody, and welcome to the second day of the 39th Annual Cowen Healthcare Conference here in Boston. It's a great pleasure to introduce David Meline, Executive Vice President and Chief Financial Officer at Amgen and Arvind Sood, Vice President of Investor Relations. I think David is going to kick it off with a few slides and then we'll open a fireside chat. You're welcome.

David W. Meline
Amgen Inc. - Executive VP & CFO

Okay, good morning. Okay, just to frame the opportunity for you as investors. If you look at the company over the last 5 years, we set out a plan for the company to transform the business. We had a number of objectives strategically as well as financially, and we are pleased to announce at year-end that we met or exceeded all of those objectives for the company. I think importantly then looking forward, we feel very good about the prospects for continued long-term growth for the company, and that's really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot